Recombinant luteinizing hormone in ovarian hyperstimulation after stimulation failure in normogonadotropic women

Gynecol Endocrinol. 1999 Apr;13(2):98-103. doi: 10.3109/09513599909167540.

Abstract

The aim of this study was to examine the effect of an additional administration of recombinant luteinizing hormone (r-LH) to a gonadotropin-releasing hormone agonist (GnRHa) long protocol using recombinant follicle-stimulating hormone (r-FSH). In particular we determined whether such a stimulation protocol would be more effective in women (1) who respond poorly to stimulation with GnRHa long protocol using r-FSH only, and (2) whose LH concentrations after down-regulation in the cancelled cycle were low but above the values reported in the literature to be sufficient for folliculogenesis. After GnRHa desensitization 150 IU r-FSH and 75 IU r-LH were administered subcutaneously daily to six normogonadotropic women with low response to ovarian hyperstimulation using a GnRHa long protocol with r-FSH and low LH concentrations after down-regulation in the cancelled cycle. All six women had an oocyte retrieval and an embryo transfer after follicular stimulation. One women conceived but had a miscarriage in the eleventh week of gestation. Our results suggest that women with low response to a GnRHa long protocol with r-FSH, and whose LH concentration after down-regulation in the cancelled cycles were low, benefit from the additional administration of r-LH in a GnRHa long protocol using r-FSH. It seems that due to the additional administration of r-LH the LH concentration in the follicular phase is sufficient to support folliculogenesis.

MeSH terms

  • Adult
  • Buserelin / therapeutic use
  • Chorionic Gonadotropin / therapeutic use
  • Embryo Transfer
  • Estradiol / blood
  • Female
  • Fertility Agents, Female / therapeutic use
  • Fertilization in Vitro
  • Follicle Stimulating Hormone / blood
  • Follicle Stimulating Hormone / therapeutic use*
  • Humans
  • Luteinizing Hormone / blood
  • Luteinizing Hormone / therapeutic use*
  • Ovary / physiology*
  • Ovulation Induction / methods*
  • Recombinant Proteins / therapeutic use*

Substances

  • Chorionic Gonadotropin
  • Fertility Agents, Female
  • Recombinant Proteins
  • Estradiol
  • Luteinizing Hormone
  • Follicle Stimulating Hormone
  • Buserelin